Us Physicalrapy Stock Alpha and Beta Analysis
| USPH Stock | USD 76.49 0.01 0.01% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as US Physicalrapy. It also helps investors analyze the systematic and unsystematic risks associated with investing in US Physicalrapy over a specified time horizon. Remember, high US Physicalrapy's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to US Physicalrapy's market risk premium analysis include:
Beta 0.64 | Alpha (0.27) | Risk 1.55 | Sharpe Ratio (0.22) | Expected Return (0.35) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
USPH |
US Physicalrapy Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. US Physicalrapy market risk premium is the additional return an investor will receive from holding US Physicalrapy long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in US Physicalrapy. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate US Physicalrapy's performance over market.| α | -0.27 | β | 0.64 |
US Physicalrapy expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of US Physicalrapy's Buy-and-hold return. Our buy-and-hold chart shows how US Physicalrapy performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.US Physicalrapy Market Price Analysis
Market price analysis indicators help investors to evaluate how US Physicalrapy stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading US Physicalrapy shares will generate the highest return on investment. By understating and applying US Physicalrapy stock market price indicators, traders can identify US Physicalrapy position entry and exit signals to maximize returns.
US Physicalrapy Return and Market Media
The median price of US Physicalrapy for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 88.55 with a coefficient of variation of 5.25. The daily time series for the period is distributed with a sample standard deviation of 4.63, arithmetic mean of 88.19, and mean deviation of 3.29. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Morgan Stanley Reduces Stake in US Physical Therapy Inc | 02/05/2025 |
2 | Disposition of 2500 shares by Eric Williams of US Physicalrapy at 104.22 subject to Rule 16b-3 | 02/14/2025 |
3 | Acquisition by Graham Reeve of 8100 shares of US Physicalrapy subject to Rule 16b-3 | 02/24/2025 |
4 | US Physical Therapy Inc Q4 2024 Everything You Need To Know Ahead Of Earnings | 02/25/2025 |
5 | Earnings To Watch US Physical Therapy Inc Reports Q4 2024 Result | 02/26/2025 |
6 | U.S. Physical Therapy Q4 Earnings Lag Estimates | 02/27/2025 |
7 | Is U.S. Physical Therapy, Inc. Potentially Undervalued | 02/28/2025 |
8 | ADUS or USPH Which Is the Better Value Stock Right Now | 03/03/2025 |
9 | Disposition of 1724 shares by Graham Reeve of US Physicalrapy at 105.46 subject to Rule 16b-3 | 03/05/2025 |
10 | Disposition of 1730 shares by Graham Reeve of US Physicalrapy at 82.11 subject to Rule 16b-3 | 03/07/2025 |
11 | Outpatient Specialty Care Stocks Q4 Results Benchmarking U.S. Physical Therapy | 03/13/2025 |
About US Physicalrapy Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including USPH or other stocks. Alpha measures the amount that position in US Physicalrapy has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | Dividend Yield | 0.0203 | 0.0183 | 0.0199 | 0.0195 | Price To Sales Ratio | 1.9 | 2.18 | 2.38 | 2.98 |
US Physicalrapy Upcoming Company Events
As portrayed in its financial statements, the presentation of US Physicalrapy's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, US Physicalrapy's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of US Physicalrapy's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of US Physicalrapy. Please utilize our Beneish M Score to check the likelihood of US Physicalrapy's management manipulating its earnings.
| 28th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 28th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with US Physicalrapy
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out US Physicalrapy Backtesting, US Physicalrapy Valuation, US Physicalrapy Correlation, US Physicalrapy Hype Analysis, US Physicalrapy Volatility, US Physicalrapy History and analyze US Physicalrapy Performance. For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
US Physicalrapy technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.